Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-01-19 00:00:00 ET · period of report 2022-01-15 · accession 0001209191-22-003854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-19 | 2022-01-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $1.05 | -190.3K | 2.24M | -8% | -$199.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-01-15 | F | D | 190,287 | $1.05 | 2,244,713 | D | — | — |